Position in TGTX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,521,233
-$979,867 QoQ
Shares Held
27,689
-63.2% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#163
of 426 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026IRIDIAN ASSET MANAGEMENT LLC/CT holds $54,664,937 across 7 Biotechnology names. TGTX ranks #5 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PGEN |
Precigen, Inc.
|
4,031,963 | $22,982,189 | |
| 2 | NVCT |
Nuvectis Pharma, Inc.
|
777,078 | $14,290,464 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
47,924 | $11,730,357 | |
| 4 | NKTR |
Nektar Therapeutics
|
38,802 | $2,708,767 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
This page
|
27,689 | $1,521,233 | |
| 6 | ABVX |
Abivax S.A.
|
9,165 | $1,221,327 | |
| 7 | BCTX |
BriaCell Therapeutics Corp.
|
65,000 | $210,600 |
All Filings in TGTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,521,233 | 27,689 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $2,501,100 | 75,289 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,244,365 | 75,289 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,719,815 | 75,289 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $1,710,676 | 47,532 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,874,186 | 47,532 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,430,713 | 47,532 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,111,773 | 47,532 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $700,161 | 39,357 | Shares | Sole | 2024-07-26 | |
| No filing history on record for this holder in this stock. | ||||||